In particular, multivariate Cox regression analysis revealed that HPSE2 methylation–expression was an independent risk factor for shortened survival among patients with CRC (RR: 1.494; 95% CI 1.056 to 2.114, P = 0.024) (Fig. 3g). Here, HPSE2 is linked to colorectal carcinoma.